Literature DB >> 3755346

Selective cytotoxic lesions of the hippocampal formation and DRL performance in rats.

J D Sinden, J N Rawlins, J A Gray, L E Jarrard.   

Abstract

Rats were given injections of ibotenic acid that made lesions of neurons throughout the hippocampus (CHC), or restricted to area CA3 (CA3), or to the subiculum (SUB), and were trained to lever press on a differential reinforcement of low rates (DRL) schedule. Their performance efficiency was compared with that of sham-operated (SO) rats in three experiments. Acquisition of DRL 12 s was only slightly impaired by any of the lesions. Increasing the DRL requirement to 18 s did not affect asymptotic efficiency of responding in the SO, CA3, or SUB group but markedly reduced efficiency in the CHC group. Administration of scopolamine reduced efficiency to the same extent in rats in all surgical treatment groups. It is concluded that hippocampal lesions made with ibotenic acid resemble conventional hippocampal lesions in their behavioral effects on DRL performance; that the behavioral effects of scopolamine administration do not appear to depend on disruption of activity of cholinoceptive cells in the hippocampal formation; and that DRL schedules, although highly sensitive to septohippocampal system disruption, discriminate more between the extent than the location of lesions in the system.

Entities:  

Mesh:

Year:  1986        PMID: 3755346     DOI: 10.1037//0735-7044.100.3.320

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  12 in total

1.  Common firing patterns of hippocampal cells in a differential reinforcement of low rates of response schedule.

Authors:  B Young; N McNaughton
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Estradiol impairs response inhibition in young and middle-aged, but not old rats.

Authors:  Victor C Wang; Steven L Neese; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2011-01-28       Impact factor: 3.763

3.  Intra-ventricular infusion of the NMDA antagonist AP5 impairs performance on a non-spatial operant DRL task in the rat.

Authors:  J Tonkiss; R G Morris; J N Rawlins
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 4.  Prospective and retrospective duration memory in the hippocampus: is time in the foreground or background?

Authors:  Christopher J MacDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-01-20       Impact factor: 6.237

5.  The effects of intrahippocampal ibotenate on resistance to extinction after continuous or partial reinforcement.

Authors:  L E Jarrard; J Feldon; J N Rawlins; J D Sinden; J A Gray
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.

Authors:  Antony D Abraham; Harrison M Fontaine; Allisa J Song; Mackenzie M Andrews; Madison A Baird; Brigitte L Kieffer; Benjamin B Land; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2017-06-26       Impact factor: 7.853

7.  Mammillary body lesions and restricted subicular output lesions produce long-lasting DRL performance impairments in rats.

Authors:  J Tonkiss; J N Rawlins
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 8.  The drugs don't work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory.

Authors:  D M Bannerman; J N P Rawlins; M A Good
Journal:  Psychopharmacology (Berl)       Date:  2006-05-05       Impact factor: 4.530

Review 9.  Time to put the mammillothalamic pathway into context.

Authors:  Christopher M Dillingham; Michal M Milczarek; James C Perry; Seralynne D Vann
Journal:  Neurosci Biobehav Rev       Date:  2020-12-09       Impact factor: 8.989

10.  Hippocampal lesions can enhance discrimination learning despite normal sensitivity to interference from incidental information.

Authors:  David J Sanderson; J Nicholas P Rawlins; Robert M J Deacon; Colm Cunningham; Chris Barkus; David M Bannerman
Journal:  Hippocampus       Date:  2011-12-07       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.